Expanding global network in the APAC medical diagnostics market
[by Ji, Yong Jun] Precision Biosensor announced on July 17 its participation in the ‘WHX (World Health Expo) Labs Kuala Lumpur 2025 (Medlab Asia),’ held in Kuala Lumpur, Malaysia, from July 16 to 18 (local time).
바카라 꽁 머니 Labs Kuala Lumpur is a medical and diagnostic exhibition representing the ASEAN and Asia-Pacific (APAC) region, celebrating its 10th anniversary this year. The event attracts over 10,000 visitors and features participation from more than 450 companies across 50 countries. It serves as a platform for showcasing a wide array of cutting-edge technologies and solutions in the medical and diagnostic industries, including in vitro diagnostics, medical devices, biomarker research, and digital healthcare.
At the exhibition, 바카라 꽁 머니 Biosensor is presenting its immunodiagnostic and clinical chemistry diagnostic platforms while actively pursuing opportunities to expand its network with local partners. Through a one-on-one (1:1) buyer meeting program, the company aims to strengthen distribution partnerships and explore new export agreements in the Asian market.
Another strategic focus involves expanding market entry opportunities in key Asian countries by networking with local hospitals and diagnostic equipment distributors. “Through this exhibition, our goal is not only to showcase our technology but also to assess the local demand and explore the potential for global market expansion based on our proprietary unique technologies,” a 바카라 꽁 머니 Biosensor official said.
On the other hand, 바카라 꽁 머니 Labs Kuala Lumpur, which also sees participation from numerous Korean companies, serves as an international stage for sharing core technologies and emerging trends in the medical and diagnostic sectors. The event consistently facilitates meaningful B2B outcomes in the industry each year.